title: The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy.
abstract: Hormone therapy is still the most commonly used treatment to relieve menopausal symptoms and the consequences of oestrogen deficiency. The decision process is complex and benefits needs to be balanced vs. risks. Not all reported benefits and risks have been as well highlighted by the media throughout recent years, it is therefore important to update regularly the current scientific knowledge. This is an actualization of the last EMAS statement concerning hormone replacement therapy use.
authors.affiliation: University Paris Descartes, APHP, Unité de Gynécologie Endocrinienne, Hôtel-Dieu de Paris, 1 Place Jean-Paul II, Paris 75004, France. anne.gompel@htd.aphp.fr
authors.forename: A
authors.initials: A
authors.lastname: Gompel
authors.forename: S
authors.initials: S
authors.lastname: Rozenberg
authors.forename: D H
authors.initials: DH
authors.lastname: Barlow
mesh_terms: D015914:Estrogen Replacement Therapy / Q000379:methods / Q000592:standards*; D005260:Female; D006801:Humans; D008875:Middle Aged